Insider Transactions in Q1 2025 at Voyager Therapeutics, Inc. (VYGR)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 21
2025
|
Alfred Sandrock President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
145,000
+24.71%
|
-
|
Feb 21
2025
|
Todd Alfred Carter Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,000
+27.1%
|
-
|
Feb 21
2025
|
Nathan D. Jorgensen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,500
+28.14%
|
-
|
Feb 21
2025
|
Toby Ferguson Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,000
+27.27%
|
-
|
Feb 21
2025
|
Sandell Jacquelyn Fahey Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+25.21%
|
-
|
Feb 21
2025
|
Robin Swartz COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
71,250
+29.58%
|
-
|
Feb 20
2025
|
Alfred Sandrock President and CEO |
SELL
Open market or private sale
|
Direct |
11,702
-3.79%
|
$46,808
$4.24 P/Share
|
Feb 20
2025
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,305
-4.08%
|
$13,220
$4.26 P/Share
|
Feb 20
2025
|
Robin Swartz COO & CBO |
SELL
Open market or private sale
|
Direct |
3,894
-3.81%
|
$15,576
$4.25 P/Share
|
Feb 11
2025
|
Alfred Sandrock President and CEO |
SELL
Open market or private sale
|
Direct |
16,644
-5.12%
|
$66,576
$4.45 P/Share
|
Feb 11
2025
|
Robin Swartz COO & CBO |
SELL
Open market or private sale
|
Direct |
6,950
-6.36%
|
$27,800
$4.45 P/Share
|
Feb 11
2025
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,413
-6.26%
|
$21,652
$4.45 P/Share
|
Feb 11
2025
|
Sandell Jacquelyn Fahey Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,358
-5.07%
|
$17,432
$4.45 P/Share
|
Jan 14
2025
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,191
-1.36%
|
$5,955
$5.13 P/Share
|
Jan 14
2025
|
Robin Swartz COO & CBO |
SELL
Open market or private sale
|
Direct |
3,087
-2.75%
|
$15,435
$5.09 P/Share
|